Plain-English translation of NCT06531434 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new approach to treating T4-stage esophageal cancer—a type where the tumor has grown into nearby organs. Instead of giving chemotherapy and radiation at the same time (which can cause dangerous side effects), this study gives chemotherapy alone first for several months, and then adds radiation only if the tumor shrinks. The goal is to help more patients recover better with fewer serious complications.
Advanced esophageal cancer is very hard to treat, and the standard approach of giving chemotherapy and radiation together causes a serious complication—a hole in the esophagus—in about 1 out of 5 patients. Researchers believe that giving the treatments in a different order might be safer and more effective.
You likely qualify if…
You likely don't qualify if…
You would receive induction chemotherapy (4 to 8 cycles over several months). After chemotherapy, doctors would scan your tumor to see if it has shrunk. If it has, you would then receive concurrent chemoradiotherapy—meaning chemotherapy given at the same time as radiation therapy. The study has two phases: Phase 1 focuses on safety, and Phase 2 evaluates how well the treatment works overall. You would have regular clinic visits for scans, blood tests, and monitoring.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Taiwan